相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study
Alice W. Lee et al.
GYNECOLOGIC ONCOLOGY (2015)
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk
Jodie N. Painter et al.
HUMAN MOLECULAR GENETICS (2015)
Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes
Hee Jeong Kim et al.
BREAST CANCER RESEARCH (2015)
The effect of metformin on breast cancer outcomes in patients with type 2 diabetes
Bridget A. Oppong et al.
CANCER MEDICINE (2014)
Activation of Endoplasmic Reticulum Stress by Hyperglycemia Is Essential for Muller Cell-Derived Inflammatory Cytokine Production in Diabetes
Yimin Zhong et al.
DIABETES (2012)
PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis
Simon M. Schultze et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2012)
The anthocyanin cyanidin-3-O-β-glucoside, a flavonoid, increases hepatic glutathione synthesis and protects hepatocytes against reactive oxygen species during hyperglycemia: Involvement of a cAMP-PKA-dependent signaling pathway
Wei Zhu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
Iris L. Romero et al.
OBSTETRICS AND GYNECOLOGY (2012)
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents
Pamela J. Goodwin et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Diabetes and Breast Cancer Among Women With BRCA1 and BRCA2 Mutations
Louise Bordeleau et al.
CANCER (2011)
TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe-/- mice
B. A. Di Bartolo et al.
DIABETOLOGIA (2011)
The impact of diabetes on survival in women with ovarian cancer
Arvind Bakhru et al.
GYNECOLOGIC ONCOLOGY (2011)
Insulin Resistance Variability in Women with Anovulatory and Ovulatory Polycystic Ovary Syndrome, and Normal Controls
L. W. Cho et al.
HORMONE AND METABOLIC RESEARCH (2011)
Glargine Promotes Proliferation of Breast Adenocarcinoma Cell Line MCF-7 via AKT Activation
J. -A. Teng et al.
HORMONE AND METABOLIC RESEARCH (2011)
Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner
R. Rattan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Genome-wide association study identifies a common variant associated with risk of endometrial cancer
Amanda B. Spurdle et al.
NATURE GENETICS (2011)
Obesity related hyperinsulinaemia and hyperglycaemia and cancer development
Susen Becker et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2011)
Metformin and Other Biguanides in Oncology: Advancing the Research Agenda
Michael Pollak
CANCER PREVENTION RESEARCH (2010)
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
Pedro Geraldes et al.
CIRCULATION RESEARCH (2010)
Metformin is a potent inhibitor of endometrial cancer cell proliferation-implications for a novel treatment strategy
Leigh A. Cantrell et al.
GYNECOLOGIC ONCOLOGY (2010)
Serum leptin-adiponectin ratio and endometrial cancer risk in postmenopausal female subjects
Naohiro Ashizawa et al.
GYNECOLOGIC ONCOLOGY (2010)
Risk of Cancer Following Hospitalization for Type 2 Diabetes
Kari Hemminki et al.
ONCOLOGIST (2010)
Role of adipokines in complications related to obesity. A review
M. Gnacinska et al.
ADVANCES IN MEDICAL SCIENCES (2009)
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
Heather A. Hirsch et al.
CANCER RESEARCH (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals
F. M. Finucane et al.
DIABETOLOGIA (2009)
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer
Geoffrey C. Kabat et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
RAGE: therapeutic target and biomarker of the inflammatory response-the evidence mounts
Ravichandran Ramasamy et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Role of genetic polymorphisms and ovarian cancer susceptibility
Peter A. Fasching et al.
MOLECULAR ONCOLOGY (2009)
AGE-RAGE system and carcinogenesis
Riichiro Abe et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer
Walter H. Gotlieb et al.
GYNECOLOGIC ONCOLOGY (2008)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic hispanics and african-americans
Anthony J. G. Hanley et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
E. Friberg et al.
DIABETOLOGIA (2007)
Prospective study of hyperglycemia and cancer risk
Par Stattin et al.
DIABETES CARE (2007)
Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria
K Rapp et al.
DIABETOLOGIA (2006)
CK2 as a positive regulator of Wnt signalling and tumourigenesis
DC Seldin et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2005)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women
WH Xu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Fasting serum glucose level and cancer risk in Korean men and women
SH Jee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Circulating adiponectin and endometrial cancer risk
L Dal Maso et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women
A Lukanova et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer
LM Berstein et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Diabetes mellitus and ovarian cancer (Sweden)
E Weiderpass et al.
CANCER CAUSES & CONTROL (2002)
Serum insulin and glucose levels and breast cancer incidence - The Atherosclerosis Risk in Communities Study
PJ Mink et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Roles of androgens in the development, growth, and carcinogenesis of the mammary gland
DJ Liao et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Energy balance and cancer: the role of insulin and insulin-like growth factor-I
R Kaaks et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2001)
Obesity, insulin, sex steroids and ovulation
JE Nestler
INTERNATIONAL JOURNAL OF OBESITY (2000)
Abnormal glucose metabolism and pancreatic cancer mortality
SM Gapstur et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
RK Ross et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Case-control study of diabetes, obesity, physical activity and risk of endometrial cancer among Mexican women
E Salazar-Martinez et al.
CANCER CAUSES & CONTROL (2000)